The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Eligibility Criteria:
You must be between the ages of 18 and 65. If you have reached your 66th birthday, you will not be able to participate.
You must have been diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or bipolar I disorder and be taking olanzapine.
You must be able to visit the doctor's office as scheduled for the next 4 months.
You may not be if
You have a history of an illness that would cause weight loss or gain in the near future.
You have taken remoxipride within the past 6 months.
You are allergic to olanzapine or Anti-obesity Agent.
You have uncontrolled high blood pressure, congestive heart failure, or have had a stroke.
You have a serious medical illness, such as heart, liver, or kidney disease.
You are pregnant or breast feeding.
Clareo Health | The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
